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Background: Atopic dermatitis (AD) is characterized by pruritic and eczematous skin lesions, which often cause 
depressive symptoms, anxiety, stress, sleep disturbances, social withdrawal, and stigmatization.
Methods: In total, 23,442 subjects (434 AD patients and 23,008 control subjects) aged 19 years or older and without 
a history of major medical illness or depressive disorders were selected from The Fifth Korea National Health and 
Nutrition Examination Survey 2007–2012. Following the initial selection, 2,170 age- and sex-matched control sub-
jects were selected using 1:5 propensity score matching. Multiple logistic regression analysis was performed to iden-
tify the presence of depressive symptoms of at least 2 weeks in duration.
Results: The demographic, socioeconomic, and clinical characteristics of AD patients and control subjects were 
presented and compared, and some variables differed significantly between groups. Presence of depressive symp-
toms was set as dependent variable, and multiple logistic regression analysis was performed as follows: (1) unad-
justed; (2) with alcohol use, exercise status, smoking status, and body mass index (BMI) adjusted for; and (3) with 
alcohol use, exercise status, smoking status, marital status, occupation, BMI, total caloric intake, history of hyper-
tension, and history of diabetes mellitus adjusted for. Depressive symptoms were significantly higher (odds ratios, 
1.46, 1.40, and 1.36; 95% confidence intervals, 1.09–1.95, 1.0.4–1.88, and 1.01–1.85, respectively) in AD patients rela-
tive to those of matched controls.
Conclusion: AD and clinical depression interact closely, and causal relationships between the two conditions have 
frequently been observed. Physicians should consider mental health interventions cautiously. It is particularly im-
portant that primary care physicians provide comprehensive, continuous long-term care.
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INTRODUCTION
Atopic dermatitis (AD) is currently one of the most prevalent 
chronic relapsing skin diseases diagnosed and treated by pri-
mary care physicians nationally in South Korea and also glob-
ally. It is characterized by pruritic and eczematous skin lesions,1) 
which often cause depressive symptoms, anxiety, stress, and 
sleep and psychological disturbances such as social withdraw-
al and stigmatization. The age of onset is between 1 year in ap-
proximately 50% of patients and 5 years in approximately 90% 
of patients, and in most cases, the skin lesions resolve before 
the patient reaches the age of 12 years.2) The lesions persist 
throughout adolescence and early adulthood in less than 10% 
of patients, who demonstrate lower levels of treatment compli-
ance and adherence, poorer quality of life, and greater psycho-
social disturbance, relative to that of younger patients.
 Recently, the need to strengthen patient education and adopt 
a multifaceted approach to the management of chronic relaps-
ing skin diseases has been emphasized in international studies, 
because the area of science known as psychodermatology is 
evolving.3) According to the categorization outlined in psycho-
dermatology, AD is a psychophysiological disorder, and while 
stress does not cause AD, it could be precipitate or exacerbate 
the condition, and emotional factors determine the natural 
course of the disease.3)
 Few studies have been conducted to examine the association 
between AD and clinically significant depressive symptoms in 
Korean adults in multicenter settings on a national scale. There-
fore, we sought to clarify the similarities and differences, with 
respect to demographic, socioeconomic, and clinical charac-
teristics, between AD patients and control subjects in the Fifth 
Korea National Health and Nutrition Examination Survey 2007–
2012 (KNHANES) and conducted multiple logistic regression 
analysis to determine whether there was a statistically signifi-
cant difference in clinically significant depressive symptoms of 
at least 2 weeks in duration between the two groups. In addi-
tion, we sought to discuss means via which primary care physi-
cians could improve AD management. This cross-sectional 
study was the first to examine the association between AD and 
mental health using KNHANES data for sufficient numbers of 
adult patients and control subjects.
METHODS
1. Subjects
Initially, 23,442 subjects were selected from the KNHANES ac-
cording to the following selection criteria: age of 19 years or 
older and no history of cancer, stroke, cardiovascular disease, 
tuberculosis, chronic obstructive pulmonary disease, bronchi-
ectasis, chronic kidney disease, thyroid disease, liver disease, 
or depressive disorders. Of the initial 23,442 subjects, 434 indi-
viduals with a current or previous diagnosis of AD and 2,170 
age- and sex-matched control subjects were selected to partici-
pate in the study.
2. Study Variables
Subjects’ demographic characteristics included age, sex, alco-
hol use, exercise status, and smoking status. Alcohol use was 
classified as follows: none, up to once per week, and at least 
twice per week. Exercise status was defined as follows: (1) in-
tensive exercise involving unusual exertion, lasting at least 10 
minutes per activity and 20 minutes per day, on at least 3 days 
during the preceding week or (2) moderate exercise, lasting at 
least 10 minutes per activity and 30 minutes or longer per day, 
on at least 5 days during the preceding week. Smoking status 
was classified as follows: none, past, or current (current smok-
ing was defined as currently smoking, with at least five packs of 
cigarettes [100 units] smoked during one’s lifetime).
 Socioeconomic characteristics included residential area, ed-
ucational level, monthly household income, marital status, and 
occupation. Educational level was classified according to the 
highest level of education attained, as follows: (1) elementary 
school or lower, (2) middle school, (3) high school, and (4) col-
lege (undergraduate) or higher. Monthly household income 
was classified according to quartiles: low (<733 US dollar [USD]), 
low medium (733–1,429 USD), medium high (1,429–2,381 USD), 
and high (>2,381 USD). Occupation was classified as follows: 
professional, managerial, semiskilled nonmanual, semiskilled 
manual, partly skilled, unskilled, and none.
 Clinical characteristics included body mass index (BMI, kg/
m2), waist circumference (cm), total caloric intake (kcal), histo-
ry of hypertension diagnosed and managed by a physician, and 
history of diabetes mellitus (DM) diagnosed and managed by a 
physician. Depressive symptoms were considered present if 
they had lasted for at least 2 weeks. Data are presented as means 
±standard errors or number (%).
3. Statistical Analysis
Descriptive analyses were conducted twice. The initial analysis 
included 23,008 control subjects and 434 AD patients. Thereaf-
ter, 2,170 age- and sex-matched control subjects were selected 
via 1:5 propensity score matching and reanalyzed. Study vari-
ables that were statistically significant in the descriptive analy-
ses were included as independent variables, with the presence 
of depressive symptoms of at least 2 weeks in duration as the 
dependent variable. Multiple logistic regression analyses were 
performed as follows: (1) unadjusted; (2) with alcohol use, ex-
ercise status, smoking status, and BMI adjusted for; and (3) with 
alcohol use, exercise status, smoking status, marital status, oc-
cupation, BMI, total caloric intake, history of hypertension, and 
history of DM adjusted for. All analyses were performed using 
SAS ver. 9.3 (SAS Institute Inc., Cary, NC, USA). Results with a 
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P-value of <0.05 were considered statistically significant.
RESULTS
AD patients’ and control subjects’ demographic (age, sex, alco-
hol use, exercise status, and smoking status), socioeconomic 
(residential area, educational level, monthly household income, 
marital status, and occupation) and clinical (BMI [kg/m2], waist 
circumference [cm], total caloric intake [kcal], history of hyper-
tension, and history of DM) characteristics are presented in Ta-
ble 1. AD patients’ mean age (39.69; SE, 15.56) was significantly 
lower relative to that of control subjects (mean age, 48.71; SE, 
16.54). With respect to sex, AD patients (180 men [41.5%] and 
254 women [58.5%]) and control subjects (9,274 men [40.3%] 
and 13,734 women [59.7%]) did not differ significantly. To im-
prove the quality of controls and accuracy of descriptive analy-
Table 1. Characteristics of atopic dermatitis patients and control subjects (unweighted data)
Variable









patients (n = 434)
P-value
Demographic characteristics
Age (y)    48.71±16.54    39.69±15.56 < 0.01    39.69±15.54    39.69±15.56 1.00
Sex 0.62 1.00
   Male 9,274 (40.3) 180 (41.5) 900 (41.5) 180 (41.5)
   Female 13,734 (59.7) 254 (58.5) 1,270 (58.5) 254 (58.5)
Alcohol use < 0.01 0.54
   None 6,324 (27.5) 88 (20.2) 448 (20.7) 88 (20.2)
   ≤ 1/wk 11,871 (51.6) 265 (61.1) 1,270 (58.5) 265 (61.1)
   ≥ 2/wk 4,813 (20.9) 81 (18.7) 452 (20.8) 81 (18.7)
Exercise status 1,666 (7.2) 44 (10.1) 0.02 178 (8.2) 44 (10.1) 0.18
Smoking 0.03 0.31
   None 14,365 (62.5) 225 (58.8) 1,354 (62.4) 255 (58.8)
   Past 2,285 (9.9) 35 (8.1) 175 (8.1) 35 (8.1)
   Current 6,358 (27.6) 144 (33.1) 641 (29.5) 144 (33.1)
Socioeconomic characteristics
Residential area 0.04 0.69
   Urban 17,399 (75.6) 347 (80.0) 1,753 (80.8) 347 (80.0)
   Rural 5,609 (24.4) 87 (20.0) 417 (19.2) 87 (20.0)
Education level < 0.01 0.74
   Elementary school or lower 5,948 (25.9) 65 (15.0) 323 (14.9) 65 (15.0)
   Middle school 2,400 (10.4) 27 (6.2) 147 (6.8) 27 (6.2)
   High school 8,027 (34.9) 175 (40.3) 922 (42.5) 175 (40.3)
   College 6,633 (28.8) 167 (38.5) 788 (35.8) 167 (38.5)
Monthly household income 0.01 0.08
   Low 4,415 (19.2) 63 (14.5) 304 (14.0) 63 (14.5)
   Low medium 5,818 (25.3) 110 (25.4) 561 (25.9) 110 (25.4)
   Medium high 6,400 (27.8) 115 (26.5) 668 (31.7) 115 (26.5)
   High 6,375 (27.7) 146 (33.6) 617 (23.4) 146 (33.6)
Marital status < 0.01 0.03
   Married 19,812 (86.1) 276 (63.6) 1,499 (69.1) 276 (63.6)
   Unmarried 246 (13.9) 158 (36.4) 671 (30.9) 158 (36.4)
Occupation < 0.01 0.06
   Professional 2,808 (12.2) 79 (18.2) 342 (15.8) 79 (18.2)
   Managerial 1,818 (7.9) 37 (8.5) 214 (9.9) 37 (8.5)
   Semiskilled nonmanual 2,843 (12.4) 76 (17.5) 289 (13.3) 76 (17.5)
   Semiskilled manual 2,212 (9.6) 25 (5.8) 137 (6.3) 25 (5.8)
   Partly skilled 2,175 (9.4) 31 (7.1) 205 (9.4) 31 (7.1)
   Unskilled 2,042 (8.9) 41 (9.5) 165 (7.6) 41 (9.5)
   None 9,110 (39.6) 145 (33.4) 818 (37.7) 145 (33.4)
Clinical characteristics
Body mass index (kg/m2)  23.61±3.37  23.55±3.67 0.73    23.22±3.55  23.55±3.67 0.08
Waist circumference (cm)  81.00±9.97    80.33±10.64 0.17      79.32±10.33    80.33±10.64 0.06
Total caloric intake (kcal) 1,918.65±834.02 1,975.15±820.76 0.16 1,980.44±853.0 1,975.15±820.76 0.91
Hypertension 4,401 (19.1) 64 (14.8) 0.02 223 (10.3) 64 (14.8) < 0.01
Diabetes mellitus 1,577 (6.9) 20 (4.6) 0.06 84 (3.9) 20 (4.6) 0.47
Depressive symptoms 2,849 (12.4) 70 (16.1) 0.02 225 (11.8) 70 (16.1) 0.01
Values are presented as mean± standard error or number (%).
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ses, 2,170 age- and sex-matched control subjects were included 
in a repeat analysis, the results of which are presented in the 
right column of Table 1.
 Alcohol use, exercise status, and smoking status differed sig-
nificantly between AD patients and unmatched control sub-
jects, but these differences did not persist in the analysis involv-
ing matched control subjects. The proportions of AD patients 
who were nondrinkers (20.2%, 88 subjects) and nonsmokers 
(58.8%, 255 subjects) were slightly lower relative to those of mat-
ched control subjects (20.7%, 448 subjects and 62.4%, 1,354 sub-
jects, respectively). In contrast, the proportion of AD patients 
who had engaged in exercise was slightly higher relative to that 
of matched control subjects (8.2%, 178 subjects).
 Of the variables representing socioeconomic status (residen-
tial area, educational level, monthly household income, mari-
tal status, and occupation), only marital status differed signifi-
cantly between AD patients and matched control subjects; con-
sequently, there was no significant difference in overall socio-
economic status between these groups. The proportion of mar-
ried AD patients (63.6%, 276 subjects) was significantly lower 
relative to that of matched control subjects (69.1%, 1,499 sub-
jects).
 With respect to depressive symptoms of at least 2 weeks in 
duration and clinical characteristics (BMI [kg/m2], waist circum-
ference [cm], total caloric intake [kcal], history of hypertension, 
and history of DM), depressive symptoms and history of hyper-
tension differed significantly between AD patients and matched 
control subjects. The proportions of AD patients with depres-
sive symptoms (16.1%, 70 subjects) and a history of hyperten-
sion (14.8%, 64 subjects) were significantly higher relative to 
those of matched control subjects (11.8%, 225 subjects and 
10.3%, 223 subjects, respectively).
 Table 2 shows the results of the multiple logistic regression 
analysis that included variables for which results of the descrip-
tive analyses were significant, as independent variables, and 
presence of depressive symptoms of at least 2 weeks in duration 
as the dependent variable. Multiple logistic regression analyses 
were performed as follows: (1) unadjusted; (2) with alcohol 
use, exercise status, smoking status, and BMI adjusted for; and 
(3) with alcohol use, exercise status, smoking status, marital 
status, occupation, BMI, total caloric intake, history of hyper-
tension, and history of DM adjusted for. In model 1, in which 
no adjustments were applied, the prevalence of depressive sym-
ptoms was significantly higher in AD patients (odds ratio, 1.46; 
95% confidence interval, 1.09–1.95), relative to that of matched 
control subjects. This difference persisted in model 2 (odds ra-
tio, 1.40; 95% confidence interval, 1.04–1.88). In model 3, all of 
the independent variables (alcohol use, exercise status, smok-
ing status, marital status, occupation, BMI, total caloric intake, 
history of hypertension, and history of DM) were adjusted for, 
and the results of multiple logistic regression analysis showed 
an odds ratio of 1.36 (95% confidence interval, 1.01–1.85), indi-
cating that the proportion of AD patients with depressive symp-
toms was 1.36 times higher relative to that of matched control 
subjects.
DISCUSSION
In total, 23,442 subjects aged 19 years or older without a history 
of major medical illnesses (i.e., cancer, stroke, cardiovascular 
disease, tuberculosis, chronic obstructive pulmonary disease, 
bronchiectasis, chronic kidney disease, thyroid disease, and 
liver disease) or depressive disorders were selected from the 
KNHANES, and multiple logistic regression analyses were per-
formed to establish the presence of depressive symptoms of at 
least 2 weeks in duration. Three models, adjusted for statisti-
cally significant differences in demographic, socioeconomic, 
and clinical characteristics (marital status and history of hyper-
tension) were produced for 434 AD patients and 2,170 age- and 
sex-matched control subjects. In all three models, levels of de-
pressive symptoms in AD patients were significantly higher 
(odds ratios, 1.46, 1.40, and 1.36; 95% confidence intervals, 1.09–
1.95, 1.04–1.88, and 1.01–1.85, respectively) relative to those of 
matched control subjects.
 Results of extensive research have shown that chronic skin 
diseases, such as AD, which characteristically involve intense 
pruritus, cause psychosocial burden. Mental health disorders, 
including ADHD (attention deficit/hyperactivity disorder), de-
pression, and autism, are known to be associated with AD.4) In 
addition, psychological disturbances, such as depression, anxi-
ety, and suicidal ideation, and high levels of stigmatization and 
social withdrawal are associated with the disease.3,5,6) The inci-
dence of three mental health comorbidities, depression, anxi-
ety, and suicidal ideation, had increased significantly in a 2015 
study involving 4,994 individuals from 13 European countries.5) 
From this perspective, psychodermatology has recently pub-
lished a number of studies that were conducted to improve both 
dermatological conditions and patients’ quality of life. The mon-
itoring of stress levels, depressive symptoms, suicidal ideation, 
Table 2. Results of multiple logistic regression analysis showing the presence of de-
pressive symptoms of at least 2 weeks in duration according to atopic dermatitis 
prevalence (unweighted data)
Control subjects Atopic dermatitis
Depression
   Model 1* 1.00 1.46 (1.09–1.95)
   Model 2† 1.00 1.40 (1.04–1.88)
   Model 3‡ 1.00 1.36 (1.01–1.85)
Values are presented as odds ratios with 95% confidence intervals in parentheses.
*Unadjusted, prevalence of atopic dermatitis in age- and sex-matched groups. 
†Alcohol use, exercise status, smoking status, and body mass index adjusted for. 
‡Alcohol use, exercise status, smoking status, marital status, occupation, body mass 
index, total caloric intake, and history of hypertension and diabetes mellitus adjusted 
for.
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and quality of sleep, which are important indices of mental heal-
th comorbidities and quality of life, should be taken into con-
sideration and incorporated into management.
 AD and clinical depression interact closely, and causal rela-
tionships between the two conditions have frequently been 
observed; for example, the onset or exacerbation of AD often 
follows stressful life events such as severe disease in a family 
member, divorce, or parental separation.7) In addition, AD pa-
tients, particularly those suffering from pruritus, experience 
psychological disturbances such as anxiety and depression. 
The following mechanisms could underlie this relationship: 
modulation of pruritus perception,8) perturbation of epidermal 
permeability barrier homeostasis,9) and acceleration of immune 
responses.10) The acceleration of interactions between the two 
conditions occurs within a vicious cycle; therefore, all physicians, 
including both psychiatrists and nonpsychiatrists, should al-
ways consider mental health interventions (psychological, be-
havioral, and psychoeducational therapies and medications 
including antidepressants and anxiolytics) cautiously. Tradi-
tionally, other than conventional lifestyle modifications, little 
assistance is provided for AD patients in most clinics in Korea, 
but those interventions are considered important in control-
ling the dermatological condition in longstanding cases. It is 
particularly important that primary care physicians provide 
comprehensive, continuous long-term care.
 Few studies have been conducted to examine mental health 
and quality of life in chronic dermatology patients in Korea; 
therefore, there is a definite need for further research to investi-
gate the association between AD and mental health in sufficient 
numbers of adult patients and control subjects, using national 
data from the KNHANES. We selected depressive symptoms of 
at least 2 weeks in duration to represent general mental health, 
as this is one of diagnostic criteria for major depressive disor-
ders in the fifth edition of the Diagnostic and Statistical Manual 
of Mental Disorders and one of the most common symptoms 
of stressful and depressive mental conditions. The proportion 
of AD patients with depressive symptoms was 1.36 times high-
er relative to that of control subjects. Many previous studies 
have involved pediatric patients; therefore, questions concern-
ing mental health and quality of life were often answered by 
parents or other caregivers rather than the patients. In contrast, 
our study included a sufficient number of adult patients, who 
had suffered from chronic relapsing conditions and were able 
to assess their own mental health and quality of life accurately.
 The only mental health variable used in the study was de-
pressive symptoms of at least 2 weeks in duration, which did 
not appear to be strong enough for the diagnosis or indication 
of major depressive or anxiety disorders. It is also limited as the 
sole indicator for need for psychiatric or psychosocial interven-
tions. Therefore, we future studies should include refined as-
sessment tools, such as questions reflecting diagnostic criteria, 
the fifth edition of the Diagnostic and Statistical Manual of Men-
tal Disorders, or severity assessments such as those of the SCOR-
ing Atopic Dermatitis Index.2,11) In addition, attempts have re-
cently been made to develop new psychosomatic scales (e.g., 
the Psychosomatic Diagnostic Criteria for Atopic Dermatitis 
and Psychosomatic Scale for Atopic Dermatitis,3,12,13) which 
should be used in future studies. Studies examining the efficacy 
of various mental health interventions, such as those mentioned 
above, should be conducted in clinical settings and include Ko-
rean adults.
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